Skip to main content

Markets Live Recap: Why Stocks Rallied to End the Week

The Dow jumped 260 points (1.1%) to close the week as oil extended its rebound from the negative $40 levels it touched Tuesday. The June 2020 crude oil contracts are now trading for about $17, which is $53 higher than the -$40 number posted earlier in the week. Despite the rebound, it's still down about 43% over the past two weeks. Investors also weighed the possibility of Gilead Science Inc.'s (NASDAQ: GILD) new drug Remdesivir treating coronavirus patients. It's to be seen whether it will be effective for the mass population or not... Here's what our experts - Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani - saw as we closed out another volatile week on Wall Street. Read more... To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Markets Live Recap: Why Stocks Rallied to End the Week appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.